Stephen W Webster - Net Worth and Insider Trading

Stephen W Webster Net Worth

The estimated net worth of Stephen W Webster is at least $731,845 dollars as of 2024-06-09. Stephen W Webster is the Director of Viking Therapeutics Inc and owns about 8,000 shares of Viking Therapeutics Inc (VKTX) stock worth over $447,920. Stephen W Webster is the CFO of Spark Therapeutics Inc and owns about 2,500 shares of Spark Therapeutics Inc (ONCE) stock worth over $283,925. Stephen W Webster is also the Director of Nabriva Therapeutics PLC and owns about 458 shares of Nabriva Therapeutics PLC (NBRVF) stock worth over $0. Details can be seen in Stephen W Webster's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Stephen W Webster has not made any transactions after 2022-08-02 and currently still holds the listed stock(s).

Transaction Summary of Stephen W Webster

To

Stephen W Webster Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Stephen W Webster owns 6 companies in total, including Nabriva Therapeutics PLC (NBRVF) , NextCure Inc (NXTC) , and TCR2 Therapeutics Inc (TCRR) among others .

Click here to see the complete history of Stephen W Webster’s form 4 insider trades.

Insider Ownership Summary of Stephen W Webster

Ticker Comapny Transaction Date Type of Owner
NBRVF Nabriva Therapeutics PLC 2022-08-02 director
NXTC NextCure Inc 2019-05-08 director
TCRR TCR2 Therapeutics Inc 2020-12-10 director
LIMIT LIMIT 2018-05-29 director
LIMIT LIMIT 2019-12-17 CHIEF FINANCIAL OFFICER
LIMIT LIMIT 2021-01-07 director

Stephen W Webster Latest Holdings Summary

Stephen W Webster currently owns a total of 3 stocks. Among these stocks, Stephen W Webster owns 8,000 shares of Viking Therapeutics Inc (VKTX) as of May 29, 2018, with a value of $447,920 and a weighting of 61.2%. Stephen W Webster owns 2,500 shares of Spark Therapeutics Inc (ONCE) as of November 16, 2017, with a value of $283,925 and a weighting of 38.8%. Stephen W Webster also owns 458 shares of Nabriva Therapeutics PLC (NBRVF) as of August 2, 2022, with a value of $0 and a weighting of 0%.

Latest Holdings of Stephen W Webster

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
VKTX Viking Therapeutics Inc 2018-05-29 8,000 55.99 447,920
ONCE Spark Therapeutics Inc 2017-11-16 2,500 113.57 283,925
NBRVF Nabriva Therapeutics PLC 2022-08-02 458 0.00 0

Holding Weightings of Stephen W Webster


Stephen W Webster Form 4 Trading Tracker

According to the SEC Form 4 filings, Stephen W Webster has made a total of 0 transactions in Viking Therapeutics Inc (VKTX) over the past 5 years. The most-recent trade in Viking Therapeutics Inc is the acquisition of 8,000 shares on May 29, 2018, which cost Stephen W Webster around $41,680.

According to the SEC Form 4 filings, Stephen W Webster has made a total of 0 transactions in Spark Therapeutics Inc (ONCE) over the past 5 years. The most-recent trade in Spark Therapeutics Inc is the sale of 10,000 shares on November 16, 2017, which brought Stephen W Webster around $701,400.

According to the SEC Form 4 filings, Stephen W Webster has made a total of 2 transactions in Nabriva Therapeutics PLC (NBRVF) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Nabriva Therapeutics PLC is the sale of 313 shares on August 2, 2022, which brought Stephen W Webster around $1,487.

Insider Trading History of Stephen W Webster

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Stephen W Webster Trading Performance

GuruFocus tracks the stock performance after each of Stephen W Webster's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Stephen W Webster is 45.02%. GuruFocus also compares Stephen W Webster's trading performance to market benchmark return within the same time period. The performance of stocks bought by Stephen W Webster within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Stephen W Webster's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Stephen W Webster

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 32.86 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 31.94 LIMIT LIMIT LIMIT LIMIT LIMIT

Stephen W Webster Ownership Network

Ownership Network List of Stephen W Webster

No Data

Ownership Network Relation of Stephen W Webster

Insider Network Chart

Stephen W Webster Owned Company Details

What does Nabriva Therapeutics PLC do?

Who are the key executives at Nabriva Therapeutics PLC?

Stephen W Webster is the director of Nabriva Therapeutics PLC. Other key executives at Nabriva Therapeutics PLC include Chief Executive Officer Hogan H Michael Iii , Chief Financial Officer David Maggio , and Chief Executive Officer Broom Colin Md .

Nabriva Therapeutics PLC (NBRVF) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Nabriva Therapeutics PLC (NBRVF) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Nabriva Therapeutics PLC (NBRVF) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Nabriva Therapeutics PLC (NBRVF)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Nabriva Therapeutics PLC Insider Transactions

No Available Data

Stephen W Webster Mailing Address

Above is the net worth, insider trading, and ownership report for Stephen W Webster. You might contact Stephen W Webster via mailing address: C/o Optimer Pharmaceuticals, Inc, 101 Hudson Street, San Diego Ca 07302.

Discussions on Stephen W Webster

No discussions yet.